COLLEEN SCHRANT: Open Payments
NPI 1922349729 · TUCSON, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,673 in 79 payments from 12 companies in 2025. Trend: 2023 $907 · 2024 $1,026 · 2025 $1,673
Food & beverage: $1,519Education: $154
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 18 | $568 |
| ABBVIE INC. | 24 | $299 |
| Janssen Biotech, Inc. | 10 | $177 |
| Galderma Laboratories, L.P. | 8 | $157 |
| SANOFI-AVENTIS U.S. LLC | 1 | $99 |
| Novartis Pharmaceuticals Corporation | 4 | $92 |
| LEO Pharma Inc. | 4 | $85 |
| Regeneron Healthcare Solutions, Inc. | 3 | $70 |
| Lilly USA, LLC | 3 | $60 |
| Organon LLC | 2 | $38 |
Products named: DUPIXENT, SKYRIZI, TREMFYA, NEMLUVIO, COSENTYX, ANZUPGO, TALTZ, VTAMA.
Industry payments across AZ — which companies pay providers there.
